Register to receive a free US Infusion Therapy Device Market report synopsis and brochure
In light of recent infusion pump product recalls, there has been a shift towards neutral displacement needleless connectors. This shift has been driven by companies like Nexus Medical and ICU Medical, with neutral displacement devices that incorporate anti-reflux technology.
The infusion therapy device market has been disrupted by product recalls affecting a significant proportion of installed base units. However, newer pump systems that incorporate additional features, such as wireless capabilities and anti-reflux technology, will enhance patient safety and drive growth.
Other key findings from the 2015 edition of the iData Research report entitled U.S. Market for Infusion Therapy Devices:
- Product Recalls: These product issues surrounding the recall have not only raised concerns about available infusion pumps, but have also put pressure on the device supply chain; infusion therapies are a significant element of medical treatment in the U.S. and at times must be replaced in high unit volumes when a recall is issued.
- Syringe Pump Market Growth: While other markets are facing competition from alternative treatments, the syringe pump market has a niche application in the neonatal intensive care unit and OR settings. Market growth is expected to continue through 2021 as analysed in this report.
- IV Fluid Shortage: Shortages of hydration fluids have required companies to import additional supplies from their manufacturing facilities abroad. This has led to a slight shift towards the use of extension IV sets at the expense of primary IV sets, further moderating market growth.
ICU Medical was the leading competitor in the U.S. needleless connector market in 2014. They are one of the few companies in this market that uses anti-reflux technology. Long-term growth will be driven by the switch to devices that incorporate anti-reflux technology. Increasing use of neutral displacement connectors is leading to an appreciation in overall market ASP.
The global series on the infusion therapy device market covers 19 countries, including the U.S., Japan, South Korea, Australia, and 15 countries in Europe. The full reports provide a comprehensive analysis including units sold, procedure numbers, market values, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.